Alcohol causes cancer at every level of drinking. Most people do not know it.
A 2025 US Surgeon General advisory put alcohol third among preventable causes of cancer. The global data show light drinking contributes too, not only heavy use.
Adding ablation to chemoembolisation extends survival in liver cancer
In the phase 3 TORCH trial, following transarterial chemoembolisation with thermal ablation more than doubled median progression-free survival, to 17.7 months from 7.3, in unresectable liver-confined cancer.
Drug therapy before surgery delayed relapse in high-risk bile-duct cancer
In a Chinese phase 2–3 trial, neoadjuvant chemotherapy, lenvatinib and a PD-1 antibody before liver surgery lifted median event-free survival to 18.0 months from 8.7. The survival signal was not yet conclusive.
WHO calls a planned hepatitis B birth-dose trial unethical; Guinea-Bissau has suspended it
The objection turns on a no-treatment arm. WHO says placebo or no-treatment vaccine trials are acceptable only where no proven intervention exists, and here one does.